Trademark Overview
On Thursday, February 2, 2023, a trademark application was filed for WUXI XDC with the United States Patent and Trademark Office. The USPTO has given the WUXI XDC trademark a serial number of 97778983. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 30, 2024. This trademark is owned by WuXi XDC Cayman Inc.. The WUXI XDC trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions...
Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates
